Actimetry Monitoring of the Paretic Upper Limb in Chronic Post Stroke.
- Conditions
- Non-use of the Paretic Upper LimbChronic Stroke
- Interventions
- Device: Wearing bracelets (3-Axis Logging Accelerometer)
- Registration Number
- NCT05581602
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
After a stroke, 80% of patients continue to have difficulty using their paretic upper limb in activities of daily living (ADL) despite post-stroke rehabilitation practices that aim to promote the use of the paretic upper limb. It is known that functional recovery depends on actual use (Use it or Loose it), but one-time measurements in the clinic do not allow quantification of the actual use of the paretic upper limb in daily life (in the person's living environment).
The investigators hypothesize the feasibility of quantifying functional use of the paretic upper limb by actimetry in clinical routine.
- Detailed Description
After a stroke, 80% of patients continue to have difficulty using their paretic upper limb in activities of daily living (ADL) despite post-stroke rehabilitation practices that aim to promote the use of the paretic upper limb. It is known that functional recovery depends on actual use (Use it or Loose it), but one-time measurements in the clinic do not allow quantification of the actual use of the paretic upper limb in daily life (in the person's living environment).
Project will monitor 30 chronic and 30 healthy subjects over one week period using two wrist worn sensors .
The main objective is to objectively quantify by actimetry, over 7 days, the real functional use of the paretic upper limb in the activities of daily living of post-stroke hemiparetic subjects in chronic phase, by the functional use ratio between the two arms (UseRatio).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 66
Inclusion criteria common to all participants:
- Be between 18 and 90 years old
Post-stroke subjects should:
- Having a stroke with motor sequelae in the upper limb
- Be in the chronic phase (>3 months post-stroke) of a stroke whatever the aetiology
Non inclusion criteria common to all participants:
- Absence of free, informed and express oral consent
- No affiliation to a French social security system or beneficiary of such a system
- Patient protected by law
- Pregnant or breastfeeding women
Not eligible for inclusion, post-stroke subjects:
- Not understanding the constraints of the study
- Have cognitive impairments that prevent them from understanding the study
- With a known hemigligence in the medical record (omission > 8 on bells test)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hemiparetic post-stroke subjects Wearing bracelets (3-Axis Logging Accelerometer) Stroke patients with motor sequelae in the upper limb. Healthy subjects Wearing bracelets (3-Axis Logging Accelerometer) Subjects without stroke.
- Primary Outcome Measures
Name Time Method FuncUseRatio 7 days The paretic functional use score is a ratio of functional movements performed by the paretic upper limb to the sum of functional movements performed by the paretic and non-paretic upper limbs (in percentage %).
- Secondary Outcome Measures
Name Time Method Use 7 days Measurement of the amount of functional movement of each upper limb, in an ecological situation during activities of daily living of post-stroke and healthy subjects.
Intensity 7 days Measurement of the intensity of movements (functional and non-functional) of each upper limb, in an ecological situation during activities of daily living of post-stroke and healthy subjects.
Motor deficit During the inclusion visit or information taken in the medical file Motor deficit will be measured by the Fugl-Meyer Upper Extremity (FM-UE)
Dispersion of UseRatio 6 months The dispersion of UseRatio (UseRatioDisp) over the 6 repeated measurements will be measured by the intra-patient interquartile range
Profil During intervention The activity log is presented in the form of a table. The columns represent the days of recording (Day 1 =\> Day 7), the rows represent the time slots hour by hour
Trial Locations
- Locations (2)
University Hospital of Montpellier
🇫🇷Montpellier, France
Jerome FROGER
🇫🇷Nîmes, France